Can be benign
Some uses of AI in this space could actually work - but only when combined with experts. for example, high quality digitisation would mean dermatologists and pathologists can share opinions and collaborate in real time, without having to wait for physical biopsies and slides to arrive; beyond that, the "simple" assessments (99%+ accuracy benign or malignant) could be removed from human assessment, maximising expert time on the complex, nuanced cases..
Later, samples can be matched with outcomes, but this has repercussions for GDPR and Personally Identifiable Information relating to health records, as well is IP and record stewardship. The urge to monetise these knowledge sets would be strong and should be rejected...Hannay Fry (of Rutherford and Fry fame) recorded an excellent piece on this on BBC sounds - https://www.bbc.co.uk/sounds/brand/m001mdn2